Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exploratory Study of High-Dose JTT-751 in Hemodialysis Patients With Chronic Kidney Disease
jRCT2080220780Phase 2
- Sponsor
- Japan Tobacco
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of ferric citrate in chronic kidney disease (CKD), sponsored by Japan Tobacco.
02
Drugs
ferric citrate
03
Conditions
chronic kidney disease (CKD)
Beyond the preview
Go deeper on jRCT2080220780.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220780.